Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Adept Technology Inc. (NASDAQ: ADEP) shares declined 9.13 percent to close at $15.02 a share Friday. The stock traded between $14.37 and $16.45 on volume of 667,909 shares traded. Analysts at Dougherty & Company have recently downgraded the company’s rating to "buy" from "strong buy". Shares of Adept Technology have gained approximately 350.0 percent in the past year.
Find out more about Adept Technology including full access to the free equity report at:
www.RDInvesting.com/ADEP
Ambarella Inc. (NASDAQ: AMBA) shares fell 8.89 percent to close at $29.31 a share Friday. The stock traded between $28.13 and $31.98 on volume of 4.26million shares traded. Analysts at Deutsche Bank have recently downgraded the company’s rating to "hold" from "buy". Shares of Ambarella have fallen approximately 130.0 percent in the past year.
Find out more about Ambarella including full access to the free equity report at:
www.RDInvesting.com/AMBA
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares declined 0.51 percent to close at $69.82 a share Friday. The stock traded between $68.31 and $70.07 on volume of 938,010 shares traded. Analysts at Barclays have recently downgraded the company’s rating to "equal weight" from "overweight". Shares of BioMarin Pharmaceutical have gained approximately 35.0 percent in the past year.
Find out more about BioMarin Pharmaceutical including full access to the free equity report at:
www.RDInvesting.com/BMRN
Splunk Inc. (NASDAQ: SPLK) shares increased 0.88 percent to close at $75.24 a share Friday. The stock traded between $71.52 and $75.29 on volume of 1.12 million shares traded. Analysts at Barclays have recently downgraded the company’s rating to "equal weight" from "overweight". Shares of Splunk have gained approximately 130.0 percent in the past year.
Find out more about Splunk including full access to the free equity report at:
www.RDInvesting.com/SPLK
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]